Pharma, Biotech and Generics Industry News | The Pharmaletter
WEBSep 27, 2024 · Pharmaceutical. 30 September 2024 India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. Generics. 30 September 2024 The number of clinical trials of new drugs in Russia is steadily declining, which could be …
Pharmaceutical Industry News | The Pharmaletter
WEBSep 24, 2024 · Centivo secures $75 million to expand affordable healthcare. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024. More Pharmaceutical News >.
About The Pharma Letter | The Pharmaletter
WEBThe Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Pharma and Biotech Regulatory News | The Pharmaletter
WEBSep 20, 2024 · FDA greenlights Genentech’s Tecentriq Hybreza. The US Food and Drug Administration (FDA) has approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), the first and only PD- (L)1 inhibitor for subcutaneous (SC) injection for patients in the USA, Swiss pharma giant Roche subsidiary Genentech announced yesterday. 13 September 2024.
Changing structure of the pharmaceutical industry in Egypt
WEBJun 23, 2022 · Despite tremendous political-economic challenges that Egypt faced in last two decades, Egypt still remains the largest producer and consumer of pharmaceuticals in the entire Middle East and Africa region with a market value of EGP 56.6billion (US$2.9 billion) in 2022 for pharmaceutical sales (Table 1).
Pharma News and Insights Podcast | The Pharmaletter
WEBJul 17, 2023 · The Pharma Letter Podcast — Episode 22 — A new way to innovate, from Flagship Pioneering. Flagship Pioneering has had an outsized impact on the sector, launching a spate of successful biotechs, including Moderna Therapeutics. Now, with Pioneering Medicines, the group hopes to shake things up again. 20 April 2023.
Humanwell Healthcare and PuraCap to acquire Epic Pharma
WEBGenerics. 8 April 2016. China-based Humanwell Healthcare Group and PuraCap Pharmaceutical have entered into a definitive agreement to acquire 100% of privately-held US generic drugs marker Epic Pharma. The acquisition, which involves a payment of $550 million, will further establish Humanwell and PuraCap in …
FDA drug regulation and approval news | The Pharmaletter
WEB6 days ago · FDA clears Dupixent, first-ever biologic for COPD. The US Food and Drug Administration (FDA) on Friday approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. 28 September 2024. Biotechnology.
BRIEF—EMA highlights 2020 drug approvals | The Pharmaletter
WEBJan 21, 2021 · The European Medicines Agency (EMA) has published an overview of its key recommendations in 2020 on the authorization and safety monitoring of medicines for human use. In 2020, the EMA recommended 97 medicines for marketing authorization. Of these, 39 had a new active substance which had never been authorized in …
New drug safety measures from EMA’s PRAC
WEBPharmaceutical. 7 September 2024. The European Medicines Agency’s (EMA) safety committee (PRAC) has recommended measures to minimize serious outcomes of agranulocytosis, a known side effect caused by the painkiller metamizole. Agranulocytosis involves a sudden and sharp decrease in granulocytes, a …